Search results
Results from the WOW.Com Content Network
Early stage GIST may be curable, but there is a risk of recurrence. The overall relative 5-year survival rate for GIST is 83 percent, but this varies by stage and other factors. Newer...
What is a 5-year relative survival rate? A relative survival rate compares people with the same type and stage of gastrointestinal stromal tumor (GIST) to people in the overall population.
A gastrointestinal stromal tumor (GIST) is a type of cancer that begins in the digestive system. GIST s happen most often in the stomach and small intestine. A GIST is a growth of cells that's thought to form from a special type of nerve cells.
The overall GIST survival rate for 5 years is 85%. However, many factors, including the tumor's size, location, and a person's age and overall health can affect their survival. Learn more...
Survival rates vary depending on tumor size and activity at the time of diagnosis, your overall health and the tumor’s response to treatment. Overall, data from the U.S. National Cancer Institute (NCI) show that 85% of people with GIST were alive five years after diagnosis.
Several factors influence the prognosis of gastrointestinal stromal tumors (GISTs), but the primary prognostic factors include the tumor staging and the tumor resectability. The staging for GISTs ranges from Stage I through Stage IV and generally follows the American Joint Committee on Cancer’s TNM system. T stands for tumor size.
The survival rate for GIST varies with the size and location of the tumor and its mitotic rate. Some GISTs are slow-growing while others grow aggressively and spread to the liver or keep recurring. The 5-year survival rate for a localized GIST is 93%.